ANGELA HAMMOUD: Open Payments
NPI 1851943930 · DEARBORN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$228 in 10 payments from 7 companies in 2025. Trend: 2023 $64 · 2024 $255 · 2025 $228
Food & beverage: $228
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 4 | $94 |
| Alkermes, Inc. | 1 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $30 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $15 |
| Corium, LLC | 1 | $8 |
Products named: FANAPT, ARISTADA, CAPLYTA, INGREZZA, UZEDY, Auvelity, Azstarys.
Industry payments across MI — which companies pay providers there.
